The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients
NCT ID: NCT01421680
Last Updated: 2014-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
144 participants
INTERVENTIONAL
2011-08-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ONS in Gastric Cancer After Total Gastrectomy
NCT05823272
Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery
NCT01838109
Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient
NCT04607057
Preoperative Oral Nutritional Supplement vs Conventional Dietary Advice in Major Gastrointestinal Surgery
NCT03315195
Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients
NCT04400552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ensure powder
Oral Nutritional Supplements with carbohydrate, lipid, protein, vitamin and minerals
Ensure powder
Ensure powder(500kcal) per day for 7 weeks
Standard care
Standard care without oral nutritional supplements
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ensure powder
Ensure powder(500kcal) per day for 7 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who undergo distal, total, proximal, or pylorus-preserving gastrectomy
* Patients who are assessed as moderate or severe malnourished according to PG-SGA or patients with BMI lower than 18.5 kg/m2
* Patients who can take oral meals
* Patients who agree on the informed consent
Exclusion Criteria
* Patients who received preoperative chemotherapy or radiation therapy within 6 months
* Pregnant patients
* Patients who cannot consume the Ensure powder
* Patients who enrolled another clinical trials
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Han-Kwang Yang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Han-Kwang Yang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Surgery, Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery, Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANSK1101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.